Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.
about
Discovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activitySelective glucocorticoid receptor-activating adjuvant therapy in cancer treatmentsEffect of the plant derivative Compound A on the production of corticosteroid-resistant chemokines in airway smooth muscle cells.Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8.Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies.Novel role for receptor dimerization in post-translational processing and turnover of the GRα
P2860
Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Combination of a selective act ...... y of hematologic malignancies.
@en
Combination of a selective act ...... y of hematologic malignancies.
@nl
type
label
Combination of a selective act ...... y of hematologic malignancies.
@en
Combination of a selective act ...... y of hematologic malignancies.
@nl
prefLabel
Combination of a selective act ...... y of hematologic malignancies.
@en
Combination of a selective act ...... y of hematologic malignancies.
@nl
P2093
P2860
P50
P356
P1433
P1476
Combination of a selective act ...... py of hematologic malignancies
@en
P2093
Alexander Popa
Alexander Yemelyanov
Gennady Belitsky
Irina Budunova
Marianna Yakubovskaya
Steven T Rosen
P2860
P304
P356
10.4161/CC.23048
P577
2012-12-19T00:00:00Z